Here's Why Mylan (MYL) Stock Is Surging Today - TheStreet.com

TheStreet.com

Here's Why Mylan (MYL) Stock Is Surging Today TheStreet.com Mylan (MYL) stock is up in late-afternoon trading on Monday after its breast cancer treatment proved comparable to a more expensive medicine by a competitor. Rachel Graf. Follow. Jun 6, 2016 3:13 PM EDT. Get TheStreet Quant Ratings' exclusive 5-page ... Cheaper Breast Cancer Drug Shows PromiseWebMD Mylan's Herceptin biosim shows comparable efficacy/safetyBioPharma Dive Study finds Mylan's biosimilar comparable to Roche cancer drugPharmacy Today, American Pharmacists Association, pharmacist.com Nasdaq -Medscape -Wall Street Journal -FierceBiotech all 63 news articles »

from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNHFUNH2A6Y5nrcePuL4zTo0c4b-Zw&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779126286493&ei=u9JVV4DzLdPRpweZoK-gDA&url=https://www.thestreet.com/story/13597849/1/here-s-why-mylan-myl-stock-is-surging-today.html
via IFTTT